Emergence of Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes in the Era of 7-Valent Conjugate Vaccine

This publication has 34 references indexed in Scilit:

• Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study
  The Lancet, 2006
• Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine
  Clinical Microbiology & Infection, 2006
• Emergence of Vaccine-Related Pneumococcal Serotypes as a Cause of Bacteremia
  Clinical Infectious Diseases, 2006
• An Outbreak of Serotype 1Streptococcus pneumoniaeMeningitis in Northern Ghana with Features That Are Characteristic ofNeisseria meningitidisMeningitis Epidemics
  The Journal of Infectious Diseases, 2005
• Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial
  The Lancet, 2005
• Emergence of Penicillin‐NonsusceptibleStreptococcus pneumoniaeClones Expressing Serotypes Not Present in the Antipneumococcal Conjugate Vaccine
  The Journal of Infectious Diseases, 2004
• Characterisation of invasive pneumococcal isolates in Catalan children up to 5 years of age, 1989–2000
  Clinical Microbiology & Infection, 2004
• A Trial of a 9-Valent Pneumococcal Conjugate Vaccine in Children with and Those without HIV Infection
  New England Journal of Medicine, 2003
• Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic Prophylaxis
  Pediatrics, 2000
• A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease
  Microbiology, 1998